Previous larger studies have reported that low levels of IgM anti-PC are associated with poor clinical outcome in patients with acute coronary syndromes [6], supporting the theory that circulating immune complexes of IgM anti-PC and PC may have atheroprotective properties [4]. Here, CD40LG is linked to acute coronary syndrome.